Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin versus daptomycin for oxacillin-resistant Staphylococcus bacteremia in hemodialysis patients
2008-005965-69Phase 4Active
- Sponsor
- Hospital Clínico San Carlos
- Start
- Feb 2010
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of daptomycin and vancomycin in Staphylococcal bacteremia (2 arms), sponsored by Hospital Clínico San Carlos. Primary endpoint: Time to blood culture negativization. Started Feb 2010; status: active.
02
Drugs
daptomycinvancomycin
03
Conditions
Staphylococcal bacteremia
Beyond the preview
Go deeper on 2008-005965-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005965-69.